tirzepatide ozempic Mounjaro® vs. Ozempic®: What's the Difference? Concerns Surrounding Compounded GLP-1s Mount

How the FDA Could Affect CIP-Related Patent Timelines The Orange Book Listing Rules and Which Secondary Patents Qualify Not every secondary patent derived from a CIP can be listed in the Orange Book

Diabetes Obes Metab 22(8):12631277

There is currently no clinical research showing that microdosing semaglutide is effective for weight management

Patients struggling with solid food intake might benefit from smoothies incorporating fruits, vegetables, protein powder, and healthy fats

Additionally, effective June 1, 2026, CVS Caremark will remove the new-to-market block on Foundayo(orforglipron), a new oral GLP-1 therapy, where approved for coverage by plans

GLP-1 receptor agonists mimic a hormone called glucagon-like peptide-1 , which increases insulin secretion, slows gastric emptying, and reduces appetite